InvestorsHub Logo
icon url

falconer66a

04/07/23 9:31 AM

#410217 RE: plexrec #410211

A simple mention? Or details?

falconer--care to comment on what Dr.Cummings is talking about--he mentions for AD disease--"changing thereputic landscape–


Will he be saying anything about Anavex’s small molecules as treatments for Alzheimer’s? If he doesn’t it will reveal that he’s ignorant of Anavex science and that he’s not presenting a wide, inclusive description of new Alzheimer’s therapies.

Most probably he will mention Anavex. But what will he say? “And there’s Anavex, with their new drug candidate blarcamesine. It’s still in clinical trials.”

Or, will he be more definitive in the status of the Anavex drug? Someone will have to report to us what he says.
icon url

nidan7500

04/07/23 9:51 AM

#410221 RE: plexrec #410211

plexrec

Dr.Cummings is talking about--he mentions for AD disease--"changing thereputic landscape--AD drug development pipeline--small molecules directed at disease modification--away from amyloid-tau theory--- kind of sounds like the Anavex MOA--platform---just my humble opinion--FWIW----https://adpd.kenes.com/hear-from-our-speakers/?fbclid=IwAR30iJdoYTmJqq7vM4NNrOPdG2lSZJYFs0x0YFG_JdgKNirTwMHPuOXikd0



EXACTLY WHAT WE HAVE SAID HERE MANY, MANY TIMES....GOOD TO SEE